These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30996176)

  • 1. Diffusion Weighted Whole Body Imaging with Background Body Signal Suppression (DWIBS) Was Useful for the Diagnosis and Follow-up of Giant Cell Arteritis.
    Matsuoka H; Yoshida Y; Oguro E; Murata A; Kuzuya K; Okita Y; Teshigawara S; Yoshimura M; Isoda K; Harada Y; Kaminou T; Ohshima S; Saeki Y
    Intern Med; 2019 Jul; 58(14):2095-2099. PubMed ID: 30996176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Diffusion-weighted Whole-body Magnetic Resonance Imaging with Background Body Signal Suppression for Assessing and Monitoring IgG4-related Disease.
    Oshita A; Kono Y; Miyoshi T; Suzuki M; Kazatani T; Matsuoka H; Kawakami H
    Intern Med; 2020 Apr; 59(7):951-955. PubMed ID: 31787698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
    Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
    Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
    Hong GS; Chae EJ; Ryu JS; Chae SY; Lee HS; Yoon DH; Suh C
    Cancer Imaging; 2021 Jan; 21(1):5. PubMed ID: 33413685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
    Soriano A; Pazzola G; Boiardi L; Casali M; Muratore F; Pipitone N; Catanoso M; Aldigeri R; Cimino L; Versari A; Salvarani C
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):99-106. PubMed ID: 29799393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.
    Baranska D; Matera K; Podgorski M; Gorska-Chrzastek M; Krajewska K; Trelinska J; Grzelak P
    MAGMA; 2019 Jun; 32(3):381-390. PubMed ID: 30498885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
    Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis.
    Oguro E; Ohshima S; Kikuchi-Taura A; Murata A; Kuzuya K; Okita Y; Matsuoka H; Teshigawara S; Yoshimura M; Yoshida Y; Isoda K; Kudo-Tanaka E; Harada Y; Kaminou T; Saeki Y
    Intern Med; 2019 May; 58(9):1355-1360. PubMed ID: 30626815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
    Maggialetti N; Ferrari C; Minoia C; Asabella AN; Ficco M; Loseto G; De Tullio G; de Fazio V; Calabrese A; Guarini A; Rubini G; Brunese L
    Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer.
    Usuda K; Iwai S; Yamagata A; Iijima Y; Motono N; Matoba M; Doai M; Yamada S; Ueda Y; Hirata K; Uramoto H
    Thorac Cancer; 2021 Mar; 12(5):676-684. PubMed ID: 33476488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse large vessel giant cell arteritis found by
    Power SP; O'Mahony D
    Lancet; 2019 Jan; 393(10169):349. PubMed ID: 30696574
    [No Abstract]   [Full Text] [Related]  

  • 15. [18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?
    Imfeld S; Aschwanden M; Rottenburger C; Schegk E; Berger CT; Staub D; Daikeler T
    Rheumatology (Oxford); 2020 Apr; 59(4):772-778. PubMed ID: 31436837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F-FDG PET/CT in a patient with clinical suspicion of giant cell arteritis].
    Altini C; Niccoli Asabella A; Rubini D; Pisani AR; Notaristefano A; Moschetta M; Giganti M; Rubini G
    Recenti Prog Med; 2013; 104(7-8):446-9. PubMed ID: 24042426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.
    Manenti G; Cicciò C; Squillaci E; Strigari L; Calabria F; Danieli R; Schillaci O; Simonetti G
    Eur J Radiol; 2012 Aug; 81(8):1917-25. PubMed ID: 21908120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Giant cell arteritis diagnosed by PET-CT scan].
    Larsen CC; Schifter S; Bonnema SJ
    Ugeskr Laeger; 2014 Apr; 176(17):. PubMed ID: 25351466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.
    Berger CT; Sommer G; Aschwanden M; Staub D; Rottenburger C; Daikeler T
    Swiss Med Wkly; 2018 Aug; 148():w14661. PubMed ID: 30141518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically isolated aortitis: imaging features and clinical outcomes: comparison with giant cell arteritis and giant cell aortitis.
    Aghayev A; Bay CP; Tedeschi S; Monach PA; Campia U; Gerhard-Herman M; Steigner ML; Mitchell RN; Docken WP; DiCarli M
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1433-1443. PubMed ID: 33128155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.